Seems a long way from here, however we all know how quick it can move when share price wants too.
This coverage is from Head of health care research at Karst Peak who is a share holder that owns 14% Neu. This should re instates the potential here and I assume other industry professional such as Neu management would support this type of coverage by the likes of Hashan.
This should not only give us an indication of the potential here but also that it will likely take a far bigger offer by way of TO to get this company in my view and rightly so.
The share price currently is a short term problem now, bouncing around $3.70-$4.50 frustrating yes, but reality is once licensing for ROW is secured and $20-$40m US upfront is received along with the milestone payment noted for $10m US, I strongly believe that this will be the catalyst to take us beyond $4.50 to $6-$7-$8.....Neu could have A$70m- A$90m in its bank account in the next few months perhaps by mid year.
I think we will see this next few months IMO...
A De-risked bio-tech with 4X upside - Karst Peak Capital, page-8
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.72 |
Change
-0.150(0.72%) |
Mkt cap ! $2.648B | |||
| Open | High | Low | Value | Volume |
| $20.96 | $21.28 | $20.61 | $4.984M | 239.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 782 | $20.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.72 | 1021 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |